Lv1
98 积分 2025-03-13 加入
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
17天前
已完结
Genome-wide CRISPR screen identifies TAF1C as an epigenetic determinant of lipid deposition via ACSL4-dependent ferroptosis in MASLD
2个月前
已完结
ZNF296 Drives Immune Evasion in Epithelial Cancers by Repressing Immune Stimulatory Genes
3个月前
已完结
Targeting TFAP2β condensation suppresses the development of esophageal squamous cell carcinoma
3个月前
已完结
DNA helix: the importance of being AT-rich
4个月前
已完结
A NF-κB-Based High-Throughput Screening for Immune Adjuvants and Inhibitors
5个月前
已完结
Predictive biomarkers for response to immune checkpoint inhibitors in lung cancer: PD-L1 and beyond
5个月前
已完结
Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells
5个月前
已完结
Impact of PD1 and PDL1 immunotherapy on non-small cell lung cancer outcomes: a systematic review
5个月前
已完结
Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis
5个月前
已完结
皖公网安备34019202002308
